Cargando…
Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19
Autores principales: | Neal, Matthew D., Lawler, Patrick R., Zarychanski, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242698/ https://www.ncbi.nlm.nih.gov/pubmed/35764486 http://dx.doi.org/10.1182/bloodadvances.2021005963 |
Ejemplares similares
-
The Impact of COVID-19 Research on the Development of Scalable Frameworks for Efficient Clinical Trials in Cardiovascular Medicine
por: Godoy, Lucas C., et al.
Publicado: (2023) -
Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the “hELP” Study
por: Simpson, Rosalind C., et al.
Publicado: (2018) -
Conflicting clinical trial data: a lesson from albumin
por: Martin, Greg
Publicado: (2005) -
Erythropoietin and organ protection: lessons from negative clinical trials
por: Pearl, Ronald G
Publicado: (2014) -
Designing for Accelerated Translation (DART) of emerging innovations in health
por: Ramsey, Alex T., et al.
Publicado: (2019)